Search clinical trials for: [18F] PBR111

Total 2547 results

M.D. Anderson Cancer Center
National Cancer Institute (NCI)

Terminated

An Investigational Scan (18F-Fluciclovine PET-CT) for the Measurement of Therapeutic Response in Patients With Metastatic Prostate Cancer

Metastatic Prostate Carcinoma | Stage IVB Prostate Cancer AJCC v8

United States
Avid Radiopharmaceuticals

Completed

Evaluation of Web-based Training to Educate Physicians in the Methods of Interpreting Florbetapir-PET Scans

Neurodegenerative Diseases | Alzheimer Disease | Mild Cognitive Impairment
Avid Radiopharmaceuticals

Completed

Evaluation of PET Scan Timing Relative to AV-45 Injection Time

Alzheimer's Disease
Avid Radiopharmaceuticals

Completed

Autopsy Follow-up of Subjects Previously Imaged With Florbetapir F 18 (18F-AV-45) PET in Trial 18F-AV-45-A07

Alzheimer's Disease

United States
Avid Radiopharmaceuticals

Completed

A Study of 18F-AV-45 in Healthy Volunteers

Alzheimer Disease

United States
University of California, Davis
National Cancer Institute (NCI); CellSight Technologies, Inc.

Withdrawn

[18F]-AraG for the Detection of T-Cell Activation in Advanced Non-small Cell Lung Cancer Patients Undergoing PD-1/PD-L1-Directed Therapy

Metastatic Lung Non-Small Cell Carcinoma | Stage IVA Lung Cancer AJCC v8 | Stage IVB Lung Cancer AJCC v8 | Stage III Lung Cancer AJCC v8 | Stage IV Lung Cancer AJCC v8 | Stage IIIA Lung Cancer AJCC v8 | Stage IIIB Lung Cancer AJCC v8 | Stage IIIC Lung Cancer AJCC v8 | Advanced Lung Non-Small Cell Carcinoma
M.D. Anderson Cancer Center
National Cancer Institute (NCI)

Completed

Fluciclovine F18 PET/CT in Identifying the Origin of Head and Neck Squamous Cell Carcinoma in Patients With Metastatic Cervical Nodal Disease

Metastatic Head and Neck Squamous Cell Carcinoma | Metastatic Squamous Cell Carcinoma in Cervical Lymph Node

United States
M.D. Anderson Cancer Center
National Cancer Institute (NCI)

Completed

F18 Fluciclovine PET/CT in Assessing Tumor Volume and Radiation Therapy Response in Patients With Glioblastoma Undergoing Surgery

Glioblastoma

United States
University of Southern California
National Institute on Aging (NIA); Northern California Institute of Research... and other collaborators

Completed

Alzheimer's Disease Neuroimaging Initiative 2 (ADNI2)

Mild Cognitive Impairment (MCI) | Alzheimer's Disease (AD) | Significant Memory Concern (SMC) | Early Mild Cognitive Impairment (EMCI) | Late Mild Cognitive Impairment (LMCI)

United States, Canada
The Cleveland Clinic
Avid Radiopharmaceuticals

Terminated

The Role of F-18 Florbetapir in the Early Detection of Cardiac Amyloidosis

Cardiac Amyloidosis

United States
University of Pennsylvania
Pennsylvania Department of Health

Recruiting

Tau Pet Imaging in the Aging Brain Cohort Dedicated to Diversity Study (ABCD2-TAU)

Alzheimer Disease | Cognitive Decline

United States
Avid Radiopharmaceuticals

Completed

Phase III Study of the Correlation Between Florbetapir F18 PET Imaging and Amyloid Pathology in the Brain

Alzheimer's Disease

United States
Genentech, Inc.

Completed

Longitudinal Evaluation of [18F]GTP1 as a PET Radioligand for Imaging Tau in the Brain of Participants With Alzheimer's Disease Compared to Healthy Participants

Alzheimer's Disease

United States
Hamad Medical Corporation

Unknown

18F-FLT (PET/CT) in Prefibrotic/Early Primary Myelofibrosis and Essential Thrombocythemia (PMF/ET-FLT)

Essential Thrombocythemia | Primary Myelofibrosis, Prefibrotic Stage | Primary Myelofibrosis, Fibrotic Stage

Qatar
Hamad Medical Corporation

Terminated

18F-FLT (PET/CT) in Pediatrics With Myeloproliferative Neoplasms

Polycythemia Vera | Essential Thrombocythemia | Primary Myelofibrosis, Prefibrotic Stage | Primary Myelofibrosis, Fibrotic Stage

Qatar
Martin Dichgans
University Hospital Muenster; Universitätsklinikum Hamburg-Eppendorf

Recruiting

Inflammatory faCtors AfteR acUte Ischemic Stroke (ICARUS)

Ischemic Stroke

Germany
Massachusetts General Hospital

Recruiting

Investigating the Utility of Demyelination Tracer [18F]3F4AP in Controls and Multiple Sclerosis Subjects

Multiple Sclerosis

United States
Rigshospitalet, Denmark

Enrolling by invitation

Dual 64Cu-DOTATATE and 18F-FDG PET/CT Imaging of Patients With Neuroendocrine Neoplasms

Neuroendocrine Tumors | Neuroendocrine Carcinoma | Neuroendocrine Carcinoma Metastatic | GEP-NET

Denmark
Avid Radiopharmaceuticals

Completed

Augmenting Flortaucipir Dosimetry Estimates

Alzheimer's Disease

United States
Avid Radiopharmaceuticals

Completed

Observational Study of Cognitive Outcomes for Subjects Who Have Had Prior PET Amyloid Imaging With Florbetapir F 18 (18F-AV-45)

Mild Cognitive Impairment | Alzheimer's Disease

United States
Solarea Bio, Inc

Active, not recruiting

Food Trial Evaluating the Efficacy of SBD111 Versus Placebo for the Clinical Dietary Management of the Metabolic Processes of Osteopenia

Osteopenia

Australia
Solarea Bio, Inc
Hebrew SeniorLife

Completed

Food Trial to Evaluate the Safety and Tolerability of SBD111 in Health Adults

Healthy

United States
Weill Medical College of Cornell University
William Rhodes Center for Glioblastoma

Recruiting

Tumor Hypoxia and Proliferation in Patients With High-Grade Glioma

Glioma

United States
Brigham and Women's Hospital
Genzyme, a Sanofi Company

Not yet recruiting

Effect of Alemtuzumab on Microglial Activation Positron Emission Tomography (PET) in Multiple Sclerosis

Multiple Sclerosis

United States
Avid Radiopharmaceuticals

Completed

18F-AV-1451 Autopsy Study

Alzheimer's Disease

United States, Australia
Avid Radiopharmaceuticals

Completed

Tau Screening Study in Patients With Early Symptomatic AD

Alzheimer Disease

United States, Canada
Genentech, Inc.

Completed

Evaluation Comparing Tau PET Radiotracers, [18F]GTP1 and [18F]PI-2620 or [18F]MK-6240 in Subjects With Normal Cognition or Prodromal to Moderate Alzheimer's Disease

Alzheimer Disease (AD)

United States
Adam Brickman
National Institute on Aging (NIA)

Completed

Alzheimer's PET Imaging in Racially/Ethnically Diverse Adults

Alzheimer Disease

United States
Avid Radiopharmaceuticals

Completed

Tau Screening Study in Subjects With Early Symptomatic AD

Alzheimer Disease

United States
Avid Radiopharmaceuticals

Completed

Florbetapir Calibration to the Centiloid Scale

Alzheimer's Disease

United States, Australia
Sanjiv Sam Gambhir
National Cancer Institute (NCI)

Completed

18F-FPPRGD2 PET/CT or PET/MRI in Predicting Early Response in Patients With Cancer Receiving Anti-Angiogenesis Therapy

Unspecified Adult Solid Tumor, Protocol Specific | Recurrent Pancreatic Cancer | Stage IV Pancreatic Cancer | Male Breast Cancer | Stage IV Breast Cancer | Stage IIIA Non-small Cell Lung Cancer | Stage IIIB Non-small Cell Lung Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Tongue Cancer | Stage... and other conditions

United States
Innervate Radiopharmaceuticals LLC (Formerly: Illumina...
Albert Einstein College of Medicine

Not yet recruiting

18F-mFBG Expression in Neural Crest Tumors and Organs Innervated by the Sympathetic Nervous System

Neuroblastoma | Pheochromocytoma | Paraganglioma

United States
William Beaumont Hospitals

Not yet recruiting

Prostate MRI and Pylarify PSMA PET/CT

Prostate Cancer
Zhe Jiang Hisun Bioray Bio-pharmaceu tical Co.Ltd

Recruiting

A Phase I Study of BR101 Injection Alone in Subjects With Advanced Solid Tumors

Advanced Solid Tumor

China
Columbia University

Active, not recruiting

Prostate Cancer Monitoring Using [18F]DCFPyL and Blood Based Biomarkers

Metastatic Prostate Cancer

United States
Chang Gung Memorial Hospital

Recruiting

Image Characteristic and Longitudinal Follow up of 18F-PMPBB3 (APN-1607) PET for Progressive Supranuclear Palsy

Progressive Supranuclear Palsy

Taiwan
Washington University School of Medicine

Recruiting

PET Imaging Study of α7 and α4β2-nAChR in Schizophrenia

Schizophrenia

United States
Massachusetts General Hospital

Active, not recruiting

Evaluation of PET/MR in Patients Selected for Ablation Therapy

Arrhythmias, Cardiac

United States
Five Eleven Pharma, Inc.

Completed

Initial Investigation of [18F]P17-059 in Parkinson's Disease Patients and Healthy Volunteers

Parkinson Disease

United States
Andrei Iagaru
National Cancer Institute (NCI)

Completed

18F-FSPG PET/CT for Cancer Patients on Therapy

Stage IIIA Non-Small Cell Lung Cancer | Stage IIIB Non-Small Cell Lung Cancer | Metastatic Renal Cell Cancer | Stage III Renal Cell Cancer | Stage IV Non-Small Cell Lung Cancer | Stage IV Breast Cancer | B-Cell Neoplasm | Stage IIIA Breast Cancer | Stage IV Renal Cell Cancer | Stage IIIC Breast Cancer | Estrogen... and other conditions

United States
American College of Radiology
National Cancer Institute (NCI); American College of Radiology Imaging Network

Terminated

Phase II Trial of 64Cu-ATSM PET/CT in Cervical Cancer (ACRIN6682)

Cervical Cancer

United States
Washington University School of Medicine
AbbVie

Terminated

Imaging Apoptosis for Lymphoma Treatment Response

Diffuse Large B Cell Lymphoma

United States
University of Pennsylvania

Terminated

[18F]FES PET/CT in PAH

Pulmonary Arterial Hypertension

United States
Sanjiv Sam Gambhir

Completed

Assessing the Suitability of an Imaging Probe for Use in Clinical Cell and Gene Therapy Trials in Cancer and Rheumatoid Arthritis

Glioma | Arthritis, Rheumatoid | Central Nervous System Neoplasms | Brain Cancer

United States
Avid Radiopharmaceuticals

Completed

Flortaucipir PET Imaging in the Preclinical, Prodromal and Dementia Phases of Alzheimer's Disease

Alzheimer Disease | Mild Cognitive Impairment
Avid Radiopharmaceuticals

Terminated

Flortaucipir 18F PET Imaging in BIOCARD Study

Cognitive Decline

United States
Avid Radiopharmaceuticals
The Cleveland Clinic

Completed

Tau Imaging in Professional Fighters

Alzheimer's Disease

United States
Molecular NeuroImaging

Completed

Evaluation of [18F]MNI-952 as a Potential PET Radioligand for Imaging Tau Protein in the Brain

Alzheimer Disease | Healthy Volunteers | Progressive Supranuclear Palsy

United States
Avid Radiopharmaceuticals

Completed

Evaluation of Flortaucipir PET Signal and Cognitive Change in Early Alzheimer's Disease

Alzheimer Disease

United States
Abramson Cancer Center at Penn Medicine

Active, not recruiting

In Vivo PARP-1 Expression With 18F-FTT PET/CT in Pancreatic Cancer

Pancreatic Cancer

United States

Search clinical trials for: [18F] PBR111

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Mauritania

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations